Product details
Catalog number BNC682300-100
Price for BNC682300-100
Size / count 1x 100 µL
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy. This MAb is excellent for staining of formalin-fixed, paraffin-embedded breast carcinomas.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF568 conjugate, 0.1mg/mL is BNC682300-100.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF568 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF568 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF568 conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF568 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF568 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd02b1061270361e109f90/msds/bnc682300-100.pdf.
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy
Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.
If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.
Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.